HTO Nevada's MAXIMUM 4% lidocaine cream (distributed by Dermal Sour) is recalled. This is a compounded or private-label topical anesthetic commonly used in aesthetic practices for pre-procedure numbing. A recall on a lidocaine cream signals potential issues with sterility, potency, or formulation stability — all critical for patient safety and treatment efficacy. If you're using this product for pre-injection or pre-laser prep, stop immediately and audit your stock. Contact your supplier to confirm whether your lot is affected and arrange replacement. Switch to a cleared, branded alternative in the interim. Document the recall and your response in your compliance file. Check the FDA enforcement page for lot numbers and distribution details.
View the official FDA record ↗
This post summarizes a public FDA database entry for medical-aesthetics owners. It is general business information, not medical, legal, or regulatory advice. Always confirm scope, lot numbers, and classification against the official FDA record, and consult your own clinician or counsel for anything clinical or compliance-related.